<DOC>
	<DOC>NCT00136201</DOC>
	<brief_summary>The primary objective of this study is to compare the safety and efficacy of an experimental antibiotic to a marketed antibiotic in the treatment of Chinese subjects with complicated intra-abdominal infections. &lt;br /&gt;</brief_summary>
	<brief_title>Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Abdominal Abscess</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>· Hospitalized male or female subjects over 18 years of age · Subjects with any concomitant condition that, in the opinion of the investigator, would preclude an evaluation of a response or make it unlikely that the contemplated course of therapy or followup visits could be completed.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Peritonitis</keyword>
	<keyword>Community-Acquired Infections</keyword>
	<keyword>Cross Infection</keyword>
</DOC>